Date	Period	Revenue/Estimate	Earnings Call
Feb 28, 2025	2024/H2	188.916M / 108.600M	--
--	2024/H1	24.327M / 24.100M	--
Feb 29, 2024	2023/H2	168.999M / 169.600M	--
Aug 28, 2023	2023/H1	64.405M / 63.100M	--
--	2022/H2	16.750M / 13.900M	--

DatePeriodRevenue/EstimateEarnings Call

Feb 28, 20252024/H2188.916M / 108.600M--

--2024/H124.327M / 24.100M--

Feb 29, 20242023/H2168.999M / 169.600M--

Aug 28, 20232023/H164.405M / 63.100M--

--2022/H216.750M / 13.900M--

Unlock Free Earnings Estimates

Open Account

Neuren Pharmaceuticals Ltd: 2024 Full Year Results webinar

Feb 27 20:10 ET

Neuren Pharmaceuticals Ltd: 2024 results - A$166m comprehensive income for shareholders

Feb 27 17:35 ET

Neuren Pharmaceuticals Ltd: Appendix 4E and 2024 full year accounts

Feb 27 17:28 ET

Neuren Pharmaceuticals Ltd: Neuren 2024 results investor webinar on 28 February 2025

Feb 26 18:24 ET

NEU Neuren Pharmaceuticals Ltd

Neuren Pharmaceuticals Ltd Key Stats